M. BEKSAÇ Et Al. , "Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002).," 44th Annual Meeting of the American-Society-of-Hematology , vol.100, PHILADELPHIA, PENNSYLVANIA, 2002
BEKSAÇ, M. Et Al. 2002. Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002).. 44th Annual Meeting of the American-Society-of-Hematology , (PHILADELPHIA, PENNSYLVANIA).
BEKSAÇ, M., Ozcan, M., Tunali, A., Dundar, S., Bayik, M., Paydas, S., ... Ali, R.(2002). Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002). . 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA
BEKSAÇ, MERAL Et Al. "Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002).," 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 2002
BEKSAÇ, MERAL Et Al. "Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002).." 44th Annual Meeting of the American-Society-of-Hematology , PHILADELPHIA, PENNSYLVANIA, 2002
BEKSAÇ, M. Et Al. (2002) . "Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002).." 44th Annual Meeting of the American-Society-of-Hematology , PHILADELPHIA, PENNSYLVANIA.
@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction. Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002).}, congress name={44th Annual Meeting of the American-Society-of-Hematology}, city={PHILADELPHIA}, country={PENNSYLVANIA}, year={2002}}